Cargando…

Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report

RATIONALE: Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a variable range of malignant potential. These neoplasms tend to have a slower growth rate than exocrine tumors and may remain undetecta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lolli, Ivan, Stasi, Elisa, Fucilli, Fabio, Pirrelli, Michele, Armentano, Raffaele, Campanella, Giovanna, Lotesoriere, Claudio, Lorusso, Dionigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500045/
https://www.ncbi.nlm.nih.gov/pubmed/28658123
http://dx.doi.org/10.1097/MD.0000000000007273
_version_ 1783248577048346624
author Lolli, Ivan
Stasi, Elisa
Fucilli, Fabio
Pirrelli, Michele
Armentano, Raffaele
Campanella, Giovanna
Lotesoriere, Claudio
Lorusso, Dionigi
author_facet Lolli, Ivan
Stasi, Elisa
Fucilli, Fabio
Pirrelli, Michele
Armentano, Raffaele
Campanella, Giovanna
Lotesoriere, Claudio
Lorusso, Dionigi
author_sort Lolli, Ivan
collection PubMed
description RATIONALE: Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a variable range of malignant potential. These neoplasms tend to have a slower growth rate than exocrine tumors and may remain undetectable for years. Achieving a correct diagnosis and staging is of key importance for the optimal management of the disease and requires experience with the disease, an accurate clinical status evaluation and a critical interpretation of the radiological findings derived from morphological and functional imaging techniques as well as an integrated multidisciplinary approach. The possibility that some clinical data and radiological findings encountered during the diagnostic and staging procedures may not be related to PNETs but to concomitant clinical conditions should always be taken into consideration. This is mandatory as an incorrect stadiation may lead to patients’ mis-management. PATIENT CONCERNS: We report the case of a 34-year-old female, with a past medical history of idiopathic acute pancreatitis, presenting with a severe upper abdominal pain, steady and radiating to the back. DIAGNOSES: Initial investigations incidentally detected a nonfunctioning pancreatic neuroendocrine tumor (NF-PNET) of intermediate grade G2. Subsequent investigations aimed at determining a correct tumor staging showed a negative indium-111- OctreoScan but an increased 18F-labeled fluorodesossiglucose (18F-FDG) uptake in multiple bilateral nodules in the lungs and in 1 nodular lesion located in the right gluteal subcutaneous tissue. An early tumor progression of a G2 NF-PNET that had to be treated with chemotherapy was suspected. INTERVENTIONS: The histological examination of the gluteal subcutaneous nodule showed noncaseating granulomas, disproving the initial clinical suspect and allowing the diagnosis of active sarcoidosis in the G2 NF-PNET patient. LESSONS: A misdiagnosis and a consequent therapeutic mismanagement were avoided with the support of an integrated multidisciplinary team.
format Online
Article
Text
id pubmed-5500045
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-55000452017-07-17 Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report Lolli, Ivan Stasi, Elisa Fucilli, Fabio Pirrelli, Michele Armentano, Raffaele Campanella, Giovanna Lotesoriere, Claudio Lorusso, Dionigi Medicine (Baltimore) 5700 RATIONALE: Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a variable range of malignant potential. These neoplasms tend to have a slower growth rate than exocrine tumors and may remain undetectable for years. Achieving a correct diagnosis and staging is of key importance for the optimal management of the disease and requires experience with the disease, an accurate clinical status evaluation and a critical interpretation of the radiological findings derived from morphological and functional imaging techniques as well as an integrated multidisciplinary approach. The possibility that some clinical data and radiological findings encountered during the diagnostic and staging procedures may not be related to PNETs but to concomitant clinical conditions should always be taken into consideration. This is mandatory as an incorrect stadiation may lead to patients’ mis-management. PATIENT CONCERNS: We report the case of a 34-year-old female, with a past medical history of idiopathic acute pancreatitis, presenting with a severe upper abdominal pain, steady and radiating to the back. DIAGNOSES: Initial investigations incidentally detected a nonfunctioning pancreatic neuroendocrine tumor (NF-PNET) of intermediate grade G2. Subsequent investigations aimed at determining a correct tumor staging showed a negative indium-111- OctreoScan but an increased 18F-labeled fluorodesossiglucose (18F-FDG) uptake in multiple bilateral nodules in the lungs and in 1 nodular lesion located in the right gluteal subcutaneous tissue. An early tumor progression of a G2 NF-PNET that had to be treated with chemotherapy was suspected. INTERVENTIONS: The histological examination of the gluteal subcutaneous nodule showed noncaseating granulomas, disproving the initial clinical suspect and allowing the diagnosis of active sarcoidosis in the G2 NF-PNET patient. LESSONS: A misdiagnosis and a consequent therapeutic mismanagement were avoided with the support of an integrated multidisciplinary team. Wolters Kluwer Health 2017-06-30 /pmc/articles/PMC5500045/ /pubmed/28658123 http://dx.doi.org/10.1097/MD.0000000000007273 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5700
Lolli, Ivan
Stasi, Elisa
Fucilli, Fabio
Pirrelli, Michele
Armentano, Raffaele
Campanella, Giovanna
Lotesoriere, Claudio
Lorusso, Dionigi
Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title_full Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title_fullStr Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title_full_unstemmed Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title_short Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
title_sort sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: a case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500045/
https://www.ncbi.nlm.nih.gov/pubmed/28658123
http://dx.doi.org/10.1097/MD.0000000000007273
work_keys_str_mv AT lolliivan sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT stasielisa sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT fucillifabio sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT pirrellimichele sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT armentanoraffaele sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT campanellagiovanna sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT lotesoriereclaudio sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport
AT lorussodionigi sarcoidosismimickingmetastaticprogressionofpancreaticneuroendocrinetumoracasereport